[HTML][HTML] Advancing personalized medicine in neurodegenerative diseases: The role of epigenetics and pharmacoepigenomics in pharmacotherapy

C Griñán-Ferré, A Bellver-Sanchis, A Guerrero… - Pharmacological …, 2024 - Elsevier
About 80% of brain disorders have a genetic basis. The pathogenesis of most
neurodegenerative diseases is associated with a myriad of genetic defects, epigenetic …

Epigenetic genes and epilepsy—emerging mechanisms and clinical applications

KMJ Van Loo, GL Carvill, AJ Becker… - Nature Reviews …, 2022 - nature.com
An increasing number of epilepsies are being attributed to variants in genes with epigenetic
functions. The products of these genes include factors that regulate the structure and …

Clinical-grade intranasal NGF fuels neurological and metabolic functions of Mecp2-deficient mice

D Pozzer, M Indrigo, M Breccia, E Florio, CA Franchino… - Brain, 2024 - academic.oup.com
MECP2 deficiency causes a broad spectrum of neuropsychiatric disorders that can affect
both genders. Rett syndrome is the most common and is characterized by an apparently …

Maternal separation affects anxiety-like behavior beginning in adolescence and continuing through adulthood and related to Dnmt3a expression

X Wang, L Jiang, W Ma, X Zheng… - Journal of …, 2022 - journals.physiology.org
Early life stress, including maternal separation, is among one of the main causes of anxiety
in adolescents. DNA methyltransferase 3A (Dnmt3a) is a key molecule that regulates DNA …

Multilevel evidence of MECP2-associated mitochondrial dysfunction and its therapeutic implications

P Balicza, A Gezsi, M Fedor, JC Sagi, A Gal… - Frontiers in …, 2024 - frontiersin.org
We present a male patient carrying a pathogenic MECP2 p. Arg179Trp variant with
predominant negative psychiatric features and multilevel evidence of mitochondrial …

Identification of molecular signatures and pathways involved in Rett syndrome using a multi-omics approach

A Pascual-Alonso, C Xiol, D Smirnov, R Kopajtich… - Human Genomics, 2023 - Springer
Background Rett syndrome (RTT) is a neurodevelopmental disorder mainly caused by
mutations in the methyl-CpG-binding protein 2 gene (MECP2). MeCP2 is a multi-functional …

Technological improvements in the genetic diagnosis of Rett syndrome spectrum disorders

C Xiol, M Heredia, A Pascual-Alonso… - International Journal of …, 2021 - mdpi.com
Rett syndrome (RTT) is a severe neurodevelopmental disorder that constitutes the second
most common cause of intellectual disability in females worldwide. In the past few years, the …

Nuclear and Cytoplasmatic Players in Mitochondria-Related CNS Disorders: Chromatin Modifications and Subcellular Trafficking

M Gasparotto, YS Lee, A Palazzi, M Vacca, F Filippini - Biomolecules, 2022 - mdpi.com
Aberrant mitochondrial phenotypes are common to many central nervous system (CNS)
disorders, including neurodegenerative and neurodevelopmental diseases. Mitochondrial …

Navigating the brain and aging: exploring the impact of transposable elements from health to disease

A Le Breton, MP Bettencourt… - Frontiers in Cell and …, 2024 - frontiersin.org
Transposable elements (TEs) are mobile genetic elements that constitute on average 45%
of mammalian genomes. Their presence and activity in genomes represent a major source …

A proteomic approach to investigate the role of the MECP2 gene mutation in Rett syndrome redox regulatory pathways

A Pasqui, V Cicaloni, L Tinti, A Guiotto, C Tinti… - Archives of Biochemistry …, 2024 - Elsevier
Mutations in the X-linked methyl-CpG-binding 2 (MECP2) gene lead to Rett Syndrome (RTT;
OMIM 312750), a devasting neurodevelopmental disorder. RTT clinical manifestations are …